Abstract
Advanced prostate cancer (PC) patients commonly receive anti-hormonal drugs targeting the androgen receptor (AR) signaling pathways. However, almost all patients acquire therapy resistance that can be caused by AR amplification or expression of AR splice variant 7 (AR-V7). Therefore, AR-V7 and AR expression are potential biomarkers for early detection of therapy resistance. Here, we present our padlock probe (PLP)-based approach for the in situ detection of AR full length, AR-V7, and prostate-specific transcripts in PC cell lines, which is applicable for circulating tumor cells (CTCs) isolated from cancer patients. First, PC cell lines are seeded on glass slides. Then, cDNA is created using target-specific reverse transcription primers. PLPs are hybridized to the cDNA and ligated to form circular single-stranded DNA molecules. The PLP sequence is ligated and amplified by rolling circle amplification and the resulting rolling circle products can be detected using fluorescently labeled probes. Quantification can be automated using the image analysis software CellProfiler.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cornford P, Bellmunt J, Bolla M et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: Treatment of relapsing, metastatic, and castration-resistant prostate cancer. Eur Urol 71:630–642. https://doi.org/10.1016/j.eururo.2016.08.002
Prekovic S, Van den Broeck T, Moris L et al (2018) Treatment-induced changes in the androgen receptor axis: liquid biopsies as diagnostic/prognostic tools for prostate cancer. Mol Cell Endocrinol 462:56–63. https://doi.org/10.1016/j.mce.2017.08.020
Stamey TA, Yang N, Hay AR et al (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317:909–916. https://doi.org/10.1056/NEJM198710083171501
Antonarakis ES, Lu C, Wang H et al (2014) AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. N Engl J Med 371:1028–1038. https://doi.org/10.1056/NEJMoa1315815
Scher HI, Lu D, Schreiber NA et al (2016) Association of AR-V7 on circulating tumor cells as a treatment-specific biomarker with outcomes and survival in castration-resistant prostate cancer. JAMA Oncol 2:1441. https://doi.org/10.1001/jamaoncol.2016.1828
Antonarakis ES, Lu C, Luber B et al (2015) Androgen receptor splice variant 7 and efficacy of taxane chemotherapy in patients with metastatic castration-resistant prostate cancer. JAMA Oncol 1:582. https://doi.org/10.1001/jamaoncol.2015.1341
El-Heliebi A, Hille C, Laxman N et al (2018) In situ detection and quantification of AR-V7, AR-FL, PSA, and KRAS point mutations in circulating tumor cells. Clin Chem 64:536–546. https://doi.org/10.1373/clinchem.2017.281295
Larsson C, Grundberg I, Söderberg O et al (2010) In situ detection and genotyping of individual mRNA molecules. Nat Methods 7:395–397. https://doi.org/10.1038/nmeth.1448
Weibrecht I, Lundin E, Kiflemariam S et al (2013) In situ detection of individual mRNA molecules and protein complexes or post-translational modifications using padlock probes combined with the in situ proximity ligation assay. Nat Protoc 8:355–372. https://doi.org/10.1038/nprot.2013.006
Krzywkowski T, Nilsson M (2018) Padlock probes to detect single nucleotide polymorphisms. In: Gaspar I (ed) RNA detection. Springer, New York, NY, pp 209–229
Larsson C, Koch J, Nygren A et al (2004) In situ genotyping individual DNA molecules by target-primed rolling-circle amplification of padlock probes. Nat Methods 1:227–232. https://doi.org/10.1038/nmeth723
Baner J, Nilsson M, Mendel-Hartvig M et al (1998) Signal amplification of padlock probes by rolling circle replication. Nucleic Acids Res 26:5073–5078. https://doi.org/10.1093/nar/26.22.5073
Carpenter AE, Jones TR, Lamprecht MR et al (2006) CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 7:R100. https://doi.org/10.1186/gb-2006-7-10-r100
Ye J, Coulouris G, Zaretskaya I et al (2012) Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 13:134. https://doi.org/10.1186/1471-2105-13-134
Ma Y, Luk A, Young F et al (2016) Droplet digital PCR based androgen receptor variant 7 (AR-V7) detection from prostate cancer patient blood biopsies. Int J Mol Sci 17:1264. https://doi.org/10.3390/ijms17081264
Al-Soud WA, Radstrom P (2001) Purification and characterization of PCR-inhibitory components in blood cells. J Clin Microbiol 39:485–493. https://doi.org/10.1128/JCM.39.2.485-493.2001
Evers DL, Fowler CB, Cunningham BR et al (2011) The effect of formaldehyde fixation on RNA. J Mol Diagn 13:282–288. https://doi.org/10.1016/j.jmoldx.2011.01.010
Yan F, Wu X, Crawford M et al (2010) The search for an optimal DNA, RNA, and protein detection by in situ hybridization, immunohistochemistry, and solution-based methods. Methods 52:281–286. https://doi.org/10.1016/j.ymeth.2010.09.005
El-Heliebi A, Kashofer K, Fuchs J et al (2017) Visualization of tumor heterogeneity by in situ padlock probe technology in colorectal cancer. Histochem Cell Biol 148:105–115. https://doi.org/10.1007/s00418-017-1557-5
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Hofmann, L., Kroneis, T., El-Heliebi, A. (2020). Using In Situ Padlock Probe Technology to Detect mRNA Splice Variants in Tumor Cells. In: Nielsen, B.S., Jones, J. (eds) In Situ Hybridization Protocols . Methods in Molecular Biology, vol 2148. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0623-0_23
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0623-0_23
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0622-3
Online ISBN: 978-1-0716-0623-0
eBook Packages: Springer Protocols